BNP Paribas Financial Markets
DYN icon

BNP Paribas Financial Markets’s Dyne Therapeutics DYN Stock Holding History

BNP Paribas Financial Markets’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528K Sell
23,786
-15,447
-39% -$287K ﹤0.01% 3730
2026
Q1 		$711K Buy
39,233
+14,727
+60% +$254K ﹤0.01% 3379
2025
Q4 		$479K Sell
24,506
-111,879
-82% -$2.12M ﹤0.01% 3594
2025
Q3 		$1.73M Sell
136,385
-140,874
-51% -$1.61M ﹤0.01% 2715
2025
Q2 		$2.64M Buy
277,259
+129,894
+88% +$1.43M ﹤0.01% 2283
2025
Q1 		$1.54M Buy
147,365
+80,367
+120% +$1.15M ﹤0.01% 2506
2024
Q4 		$1.58M Buy
+66,998
New +$1.98M ﹤0.01% 2520

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BNP Paribas Financial Markets's DYN Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Dyne Therapeutics (DYN) stake by 39% in Q2 2026, selling an estimated $287K and leaving 23,786 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #3730.

BNP Paribas Financial Markets first reported a position in DYN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.64M in Q2 2025. 230 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • BNP Paribas Financial Markets held 23,786 shares of Dyne Therapeutics worth $528K as of Q2 2026.
  • BNP Paribas Financial Markets sold 15,447 Dyne Therapeutics shares in Q2 2026, an estimated $287K.
  • Dyne Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3730 holding.
  • BNP Paribas Financial Markets first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Dyne Therapeutics position peaked at $2.64M in Q2 2025.
  • 230 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.